JUBI-R will require to be administered intravenously in a hospital setting under medical supervision.JUBI-R will be sold at ₹4,700 per vial in the Indian market
from Livemint - Companies https://ift.tt/3kaiyfm
https://ift.tt/eA8V8J
Monday, August 3, 2020
Jubilant Generics launches remdesivir under ‘JUBI-R’ brand
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment